- Home
- ADD vs RFL Comparison
ADD vs RFL Comparison
Compare ADD & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADD
- RFL
- Stock Information
- Founded
- ADD 2002
- RFL 2017
- Country
- ADD United States
- RFL United States
- Employees
- ADD N/A
- RFL 13
- Industry
- ADD Engineering & Construction
- RFL Real Estate
- Sector
- ADD Consumer Discretionary
- RFL Finance
- Exchange
- ADD Nasdaq
- RFL Nasdaq
- Market Cap
- ADD 33.8M
- RFL 41.0M
- IPO Year
- ADD N/A
- RFL N/A
- Fundamental
- Price
- ADD $1.32
- RFL $1.63
- Analyst Decision
- ADD
- RFL
- Analyst Count
- ADD 0
- RFL 0
- Target Price
- ADD N/A
- RFL N/A
- AVG Volume (30 Days)
- ADD 487.0K
- RFL 17.7K
- Earning Date
- ADD 06-01-2024
- RFL 10-28-2024
- Dividend Yield
- ADD N/A
- RFL N/A
- EPS Growth
- ADD N/A
- RFL N/A
- EPS
- ADD N/A
- RFL N/A
- Revenue
- ADD $1,060,442.00
- RFL $540,000.00
- Revenue This Year
- ADD N/A
- RFL N/A
- Revenue Next Year
- ADD N/A
- RFL N/A
- P/E Ratio
- ADD N/A
- RFL N/A
- Revenue Growth
- ADD N/A
- RFL 92.86
- 52 Week Low
- ADD $0.17
- RFL $1.29
- 52 Week High
- ADD $1.86
- RFL $2.30
- Technical
- Relative Strength Index (RSI)
- ADD 77.70
- RFL 62.37
- Support Level
- ADD $0.57
- RFL $1.49
- Resistance Level
- ADD $1.49
- RFL $1.67
- Average True Range (ATR)
- ADD 0.21
- RFL 0.07
- MACD
- ADD 0.07
- RFL 0.02
- Stochastic Oscillator
- ADD 96.25
- RFL 82.08
About ADD Color Star Technology Co. Ltd.
Color Star Technology Co Ltd is an entertainment technology and education company providing online and offline music education. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.